Skip to main content

Summary

What it measures:

Used to measure Parkinson disease progression and monitor response to treatment.

Target Population:

People with Parkinson disease (PD); Mild/Early, Moderate/Middle, Severe/Late stages

Test description:

Uses combination of patient self-report and physical examination

Contains questions related to underlying impairments (11 items), activities of daily living (ADLs) (10 items), and cognition/affect (3 items)

Each item scored on a 0-4 ordinal scale, with higher scores representing greater severity (0=no problem, 4=an important issue to the patient)


You Might Also Like...

CPG

Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline from the American Physical Therapy Association (CPG+)

Dec 28, 2021

Related Resources Parkinson Disease CPG Toolkit Pocket Guide  CPG+ Appraisal Rating 6 out of 7 (How was this rating made?)  Highlights This CPG provides

CPG

The First Global Physical Activity and Sedentary Behavior Guidelines for People Living With Disability

Jan 3, 2021

This guideline presents 10 areas for advancing inclusive practice in physical activity and sedentary behavior for people living with disability.

CPG

Canadian Guideline for Parkinson Disease

Sep 9, 2019

Patients in the early stages of Parkinson’s disease should be referred to a physical therapist who has experience with the disease for assessment, education,